2.40
price down icon0.21%   -0.01
 
loading

Perché le azioni Erasca Inc (ERAS) sono in ribasso?

Abbiamo notato un calo di 5.24% nelle azioni di Erasca Inc (ERAS) durante la sessione di negoziazione di 2025-09-25. Sebbene ciò possa essere attribuito alla normale volatilità o a vari fattori interni ed esterni, tieni presente che stiamo monitorando attivamente la situazione e forniremo aggiornamenti tempestivi il prima possibile!
2023-11-28:

Shares of Erasca Inc (ERAS) dropped by 11.38% from $2.24 to $1.99 in the trading on Tuesday, November 28, 2023. The reason why ERAS is down today is due to the company's program updates, particularly regarding its SEACRAFT-2 Phase 3 trial for Naporafenib Plus Trametinib and its THUNDERBBOLT-1 Phase 1 trial for ERAS-801. Investors may have been concerned about the trial details, including the patient population and comparator arm in SEACRAFT-2, as well as the need for additional data for ERAS-801. Additionally, the company's decision to deprioritize certain programs and focus on more promising initiatives could have contributed to the stock's decline.

$84.29
price up icon 0.70%
$23.04
price up icon 7.54%
$32.16
price up icon 1.13%
$103.25
price up icon 1.17%
$165.07
price up icon 1.70%
biotechnology ONC
$328.93
price up icon 2.96%
Capitalizzazione:     |  Volume (24 ore):